| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.92▼ | 4.88▲ | 4.89▲ | 5.29▼ | 5.59▼ |
| MA10 | 4.89▲ | 4.87▲ | 5.01▼ | 5.60▼ | 5.56▼ |
| MA20 | 4.89▲ | 5.03▼ | 5.13▼ | 5.75▼ | 5.01▼ |
| MA50 | 4.87▲ | 5.23▼ | 5.57▼ | 5.58▼ | 5.04▼ |
| MA100 | 4.99▼ | 5.59▼ | 5.67▼ | 5.04▼ | 3.48▲ |
| MA200 | 5.12▼ | 5.72▼ | 5.74▼ | 5.29▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.007▲ | 0.004▲ | -0.013▼ | -0.122▼ | -0.007▼ |
| RSI | 57.901▲ | 38.151▼ | 31.595▼ | 35.986▼ | 47.443▼ |
| STOCH | 90.362▲ | 50.280 | 20.524 | 23.738 | 50.394 |
| WILL %R | -27.273 | -70.492 | -70.492 | -88.462▼ | -59.943 |
| CCI | 117.785▲ | -10.324 | -63.511 | -185.297▼ | -60.570 |
|
Thursday, September 10, 2026 10:35 PM
On August 11, Zura Bio (NASDAQ:ZURA) reported second-quarter results that landed on an unusual mix of good and bad news. The clinical-stage biotech finished enrolling two separate Phase 2 studies of ...
|
|
Friday, August 21, 2026 12:57 PM
HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) (“Zura” or the “Company”), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully ...
|
|
Wednesday, March 04, 2026 04:00 PM
HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) (“Zura”), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/09/26 | 5.12 | 5.12 | 4.74 | 4.92 | 2,611,996 |
| 14/09/26 | 5.21 | 5.36 | 5.15 | 5.21 | 1,045,393 |
| 11/09/26 | 5.48 | 5.58 | 5.15 | 5.21 | 1,420,981 |
| 10/09/26 | 5.60 | 5.74 | 5.365 | 5.38 | 1,149,722 |
| 09/09/26 | 6.04 | 6.0502 | 5.63 | 5.71 | 1,729,686 |
| 08/09/26 | 6.23 | 6.23 | 5.90 | 6.13 | 1,613,630 |
| 04/09/26 | 5.80 | 6.26 | 5.6296 | 6.23 | 1,387,299 |
| 03/09/26 | 5.69 | 5.94 | 5.50 | 5.88 | 1,681,037 |
| 02/09/26 | 5.67 | 5.87 | 5.485 | 5.67 | 934,092 |
| 01/09/26 | 5.52 | 5.68 | 5.39 | 5.65 | 1,096,127 |
|
|
||||
|
|
||||
|
|